ACCENTIS NV (ACCB.BR)       0.0292  0 (-1.35%)

0.0292  0 (-1.35%)

BE0003696102 - Common Stock


Fundamental Rating

3

Overall ACCB gets a fundamental rating of 3 out of 10. We evaluated ACCB against 24 industry peers in the Real Estate Management & Development industry. ACCB has a great financial health rating, but its profitability evaluates not so good. ACCB is valued expensive and it does not seem to be growing.

Note: ACCB has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

The Piotroski-F score of ACCB is 6.00. This is a neutral score and indicates average health and profitability for ACCB.
ACCB's Return On Assets of 1.62% is worse than the rest of the industry. The industry average Return On Assets is 2.64%.

ACCB's Return On Equity of 2.66% is worse than the rest of the industry. The industry average Return On Equity is 7.36%.
ACCB's Profit Margin of 8.34% is worse than the rest of the industry. The industry average Profit Margin is 30.36%. 85% of the industry peers have a better Profit Margin.
VS Industry

ROA (1.62%) VS Industry: 26% outperformed.

0.60
12.32

ROE (2.66%) VS Industry: 21% outperformed.

2.46
27.51

Profit Margin (8.34%) VS Industry: 15% outperformed.

3.93
978.77

Valuation

Valuation Rating

1

When comparing the current price to the book value of ACCB, we can conclude it is valued correctly. It is trading at 1.03 times its book value.

Compared to an average industry price book ratio of 0.58, ACCB is valued more expensive than its industry peers. 92% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Book (1.03) VS Industry: 8% outperformed.

1.46
0.01

Growth

Growth Rating

0

ACCB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.43%.
ACCB shows a very negative growth in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -40.43% yearly.

Looking at the last year, ACCB shows a very negative growth in Revenue. The Revenue has decreased by -45.63% in the last year.
ACCB shows a very negative growth in Revenue. Measured over the last 5 years, the Revenue has been decreasing by -17.20% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-40.43% -64.84% -94.43% N/A N/A N/A N/A
Revenue-17.2% -27.29% -45.63% N/A N/A N/A N/A

Health

Health Rating

9

ACCB has a Current Ratio of 3.48. This indicates that ACCB is financially healthy and has no problem in meeting its short term obligations.
ACCB is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.99. ACCB has a better rating than 86% of its industry peers.
A Quick Ratio of 3.48 indicates that ACCB has no problem at all paying its short term obligations.
The Quick Ratio of ACCB is much better than the industry average of 1.37. ACCB has a better rating than 86% of its industry peers.

The Debt to Equity ratio of ACCB is way better than the industry averages. ACCB has a better rating than 82% of its industry peers.
The Altman-Z score of ACCB is much better than the industry average of 0.90. ACCB has a better rating than 91% of its industry peers.
An Altman-Z score of 1.93 indicates that ACCB is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Piotroski-F score of ACCB is 6.00. This is a neutral score and indicates average health and profitability for ACCB.
VS Industry

Debt/Equity (0.39) VS Industry: 82% outperformed.

2.45
0.00

Quick Ratio (3.48) VS Industry: 86% outperformed.

0.16
4.40

Current Ratio (3.48) VS Industry: 86% outperformed.

0.26
5.89

Altman-Z (1.93) VS Industry: 91% outperformed.

-3.37
2.18

Dividend

Dividend Rating

0

ACCB does not give a dividend.

ACCENTIS NV0.0292

EBR:ACCB (3/29/2023, 7:00:00 PM)0 (-1.35%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupReal Estate
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap36.88M
AnalystsN/A
Price TargetN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP1196.42%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.24
P/FCF 13.55
P/OCF 13.55
P/B 1.03
P/tB 1.03
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY7.38%
OCF(TTM)0
OCFY7.38%
SpS0.01
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.62%
ROE 2.66%
ROIC 6.64%
ROICexc 8.25%
ROICexgc 8.25%
OM 52.22%
PM 8.34%
GM 50.42%
ROICexgc(3y)7.99%
ROICexcg growth 3Y6.91%
ROICexcg growth 5Y-0.24%
ROICexc(3y)7.99%
ROICexc growth 3Y6.91%
ROICexc growth 5Y-0.24%
OM growth 3Y3.33%
OM growth 5Y-1.45%
PM growth 3Y-51.8%
PM growth 5Y-28.2%
GM growth 3Y3.54%
GM growth 5Y-1%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 6.09
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality 286.42%
Current Ratio 3.48
Quick Ratio 3.48
Altman-Z 1.93
F-Score6
WACC6.17%
ROIC/WACC1.34
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Profit Quality(3y)341.55%
Profit Quality(5y)253.91%
Growth
EPS 1Y-94.43%
EPS 3Y-64.84%
EPS 5Y-40.43%
EPS growth Q2Q-97.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1Y-45.63%
Revenue growth 3Y-27.29%
Revenue growth 5Y-17.2%
Revenue growth Q2Q-25.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.46%
EBIT growth 3Y-24.88%
EBIT growth 5Y-18.4%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.71%
FCF growth 3Y-27.99%
FCF growth 5Y-21.43%
OCF growth 1Y-29.74%
OCF growth 3Y-27.99%
OCF growth 5Y-21.43%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext